Clinical Trials Search

Titlesort descending Intervention NCT ID Sponsor Status
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... Curcumin, Laboratory Biomarker Analysis, Placebo, Quality-of-Life Assessment NCT02782949 National Cancer Institute (NCI) Recruiting
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer Internet-Based Intervention, Best Practice, Quality-of-Life Assessment, Questionnaire Administration, Survey Administration, Laboratory Biomarker Analysis NCT03103321 Alliance for Clinical Trials in Oncology Active, not recruiting
Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer Everolimus, Quality-of-Life Assessment, Questionnaire, Placebo, Dexamethasone NCT03839940 Alliance for Clinical Trials in Oncology Recruiting
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients... Behavioral Dietary Intervention, Compliance Monitoring, Counseling, Educational Intervention, Exercise Intervention, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration NCT00719303 Gynecologic Oncology Group Recruiting
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer Digital Mammography, Digital Tomosynthesis Mammography, Laboratory Biomarker Analysis NCT03233191 ECOG-ACRIN Cancer Research Group Recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection DNA Plasmid Encoding Interleukin-12 INO-9012, Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment NCT02772003 National Cancer Institute (NCI) Active, not recruiting
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American... Questionnaire Administration, Quality-of-Life Assessment, Paclitaxel, Docetaxel NCT04001829 ECOG-ACRIN Cancer Research Group Recruiting
Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers Laboratory Biomarker Analysis, Placebo, Questionnaire Administration, Dolcanatide NCT03300570 National Cancer Institute (NCI) Active, not recruiting
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III... Placebo, Questionnaire Administration, Quality-of-Life Assessment, Duloxetine, Duloxetine Hydrochloride, Oxaliplatin NCT04137107 Alliance for Clinical Trials in Oncology Not yet recruiting
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer Questionnaire Administration, Interview NCT03963739 Wake Forest University Health Sciences Recruiting

Pages